A detailed history of Legal & General Group PLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Legal & General Group PLC holds 368,021 shares of DVAX stock, worth $4.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
368,021
Previous 368,021 -0.0%
Holding current value
$4.49 Million
Previous $4.1 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.05 - $11.61 $184,648 - $213,310
-18,373 Reduced 4.75%
368,021 $4.1 Million
Q2 2024

Aug 14, 2024

BUY
$10.73 - $12.58 $217,121 - $254,556
20,235 Added 5.53%
386,394 $4.34 Million
Q1 2024

Jul 01, 2024

BUY
$11.7 - $14.98 $83,011 - $106,283
7,095 Added 1.98%
366,159 $4.54 Million
Q1 2024

May 14, 2024

SELL
$11.7 - $14.98 $86,755 - $111,076
-7,415 Reduced 2.02%
359,064 $4.46 Million
Q4 2023

Feb 15, 2024

BUY
$13.09 - $14.98 $32,738 - $37,464
2,501 Added 0.69%
366,479 $5.12 Million
Q3 2023

Nov 14, 2023

BUY
$12.64 - $14.99 $242,991 - $288,167
19,224 Added 5.58%
363,978 $5.38 Million
Q2 2023

Aug 14, 2023

BUY
$9.85 - $13.17 $463,905 - $620,267
47,097 Added 15.82%
344,754 $4.45 Million
Q1 2023

May 15, 2023

SELL
$9.44 - $11.88 $6,570 - $8,268
-696 Reduced 0.23%
297,657 $2.92 Million
Q4 2022

Feb 14, 2023

BUY
$10.27 - $13.29 $89,503 - $115,822
8,715 Added 3.01%
298,353 $3.17 Million
Q3 2022

Nov 14, 2022

SELL
$9.93 - $17.44 $60,771 - $106,732
-6,120 Reduced 2.07%
289,638 $3.02 Million
Q2 2022

Aug 22, 2022

BUY
$7.45 - $12.83 $1.77 Million - $3.06 Million
238,178 Added 413.65%
295,758 $3.72 Million
Q1 2022

May 16, 2022

BUY
$9.75 - $14.44 $14,683 - $21,746
1,506 Added 2.69%
57,580 $624,000
Q4 2021

Feb 14, 2022

BUY
$13.17 - $20.94 $1,619 - $2,575
123 Added 0.22%
56,074 $789,000
Q3 2021

Nov 15, 2021

BUY
$9.16 - $19.83 $224,136 - $485,220
24,469 Added 77.72%
55,951 $1.08 Million
Q2 2021

Aug 12, 2021

BUY
$7.25 - $10.99 $2,160 - $3,275
298 Added 0.96%
31,482 $310,000
Q1 2021

May 17, 2021

SELL
$4.57 - $11.18 $60,726 - $148,559
-13,288 Reduced 29.88%
31,184 $306,000
Q4 2020

Feb 12, 2021

BUY
$3.73 - $5.6 $94,958 - $142,564
25,458 Added 133.89%
44,472 $198,000
Q3 2020

Nov 13, 2020

SELL
$4.32 - $11.7 $8,968 - $24,289
-2,076 Reduced 9.84%
19,014 $83,000
Q2 2020

Aug 14, 2020

BUY
$2.94 - $9.1 $11,271 - $34,889
3,834 Added 22.22%
21,090 $187,000
Q1 2020

May 14, 2020

SELL
$2.27 - $6.2 $9,032 - $24,669
-3,979 Reduced 18.74%
17,256 $61,000
Q4 2019

Feb 13, 2020

BUY
$3.46 - $6.93 $9,639 - $19,306
2,786 Added 15.1%
21,235 $121,000
Q3 2019

Nov 13, 2019

BUY
$2.69 - $4.85 $17,848 - $32,179
6,635 Added 56.16%
18,449 $66,000
Q4 2018

Feb 15, 2019

BUY
$8.14 - $13.28 $15,140 - $24,700
1,860 Added 18.69%
11,814 $108,000
Q2 2018

Aug 10, 2018

SELL
$15.15 - $20.75 $19,513 - $26,726
-1,288 Reduced 11.46%
9,954 $152,000
Q1 2018

May 17, 2018

SELL
$14.65 - $19.9 $58,277 - $79,162
-3,978 Reduced 26.14%
11,242 $223,000
Q4 2017

Feb 13, 2018

BUY
$17.3 - $24.08 $263,306 - $366,497
15,220
15,220 $287,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.54B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.